National Guidelines

2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 80(14), 1366–1418

Lloyd-Jones, D. M., Morris, P. B., Ballantyne, C. M., Birtcher, K. K., Covington, A. M., DePalma, S. M., Minissian, M. B., Orringer, C. E., Smith, S. C., Waring, A. A., & Wilkins, J. T. 

Download the full PDF file

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 78(9), 960–993

Virani, S. S., Morris, P. B., Agarwala, A., Ballantyne, C. M., Birtcher, K. K., Kris-Etherton, P. M., Ladden-Stirling, A. B., Miller, M., Orringer, C. E., & Stone, N. J. 

Download the full PDF file

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M. Grundy, MD, PhD, FAHA, Chair, Writing Committee, Neil J. Stone, MD, FACC, FAHA, Vice Chair, Writing Committee, Alison L. Bailey, MD, FACC, FAACVPR, Writing Committee Member, Craig Beam, CRE, Writing Committee Member, Kim K. Birtcher, MS, PharmD, AACC, FNLA, Writing Committee Member, Roger S. Blumenthal, MD, FACC, FAHA, FNLA, Writing Committee Member, Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FNLA, Writing Committee Member, Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FNLA, Writing Committee Member, Sarah de Ferranti, MD, MPH, Writing Committee Member, Joseph Faiella-Tommasino, PhD, PA-C, Writing Committee Member, Daniel E. Forman, MD, FAHA, Writing Committee Member, Ronald Goldberg, MD, Writing Committee Member, Paul A. Heidenreich, MD, MS, FACC, FAHA, Writing Committee Member, Mark A. Hlatky, MD, FACC, FAHA, Writing Committee Member, Daniel W. Jones, MD, FAHA, Writing Committee Member, Donald Lloyd-Jones, MD, SCM, FACC, FAHA, Writing Committee Member, Nuria Lopez-Pajares, MD, MPH, Writing Committee Member, Chiadi E. Ndumele, MD, PhD, FAHA, Writing Committee Member, Carl E. Orringer, MD, FACC, FNLA, Writing Committee Member, Carmen A. Peralta, MD, MAS, Writing Committee Member, Joseph J. Saseen, PharmD, FNLA, FAHA, Writing Committee Member, Sidney C. Smith, Jr., MD, MACC, FAHA, Writing Committee Member, Laurence Sperling, MD, FACC, FAHA, FASPC, Writing Committee Member, Salim S. Virani, MD, PhD, FACC, FAHA, Writing Committee Member, Joseph Yeboah, MD, MS, FACC, FAHA, Writing Committee Member

Download the full PDF file

Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel III)

Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) presents the National Cholesterol Education Program (NCEP) updated recommendations on cholesterol testing and management. The ATP III document is an evidence-based report that provides the scientific rationale for the recommendations contained in the Executive Summary

ATP III is constructed on the foundation of ATP I and ATP II, with low density lipoprotein (LDL) continuing to be identified as the primary target of cholesterol lowering therapy.

New features of ATP III include:

• Aggressive treatment of persons who are at relatively high risk for coronary heart disease due to multiple risk factors
• Use of the lipoprotein profile as the first test for high cholesterol
• A new level at which low HDL (high density lipoprotein) becomes a major heart disease risk factor
• A new set of "Therapeutic Lifestyle Changes" to improve cholesterol levels
• An increased focus on a cluster of heart disease risk factors knows as "the metabolic syndrome"
• Increased attention to the treatment of high triglycerides

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic
Cardiovascular Risk in Adults

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Neil J. Stone, MD, MACP, FAHA, FACC; Jennifer Robinson, MD, MPH, FAHA; Alice H. Lichtenstein, DSc, FAHA; C. Noel Bairey Merz, MD, FAHA, FACC; Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA; Conrad B. Blum, MD, FAHA; Patrick McBride, MD, MPH, FAHA; Robert H. Eckel, MD, FAHA; J. Sanford Schwartz, MD; Anne C. Goldberg, MD, FACP, FAHA; Susan T. Shero, MS, RN; David Gordon, MD; Sidney C. Smith, MD, FACC, FAHA; Daniel Levy, MD; Karol Watson, MD, PhD, FACC, FAHA; Peter W.F. Wilson, MD, FAHA

Download the full PDF file

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

>Robert H. Eckel, MD, FAHA; John M. Jakicic, PhD; Jamy D. Ard, MD; Nancy Houston Miller, RN, BSN, FAHA; Van S. Hubbard, MD, PhD; Cathy A. Nonas, MS, RD; Janet M. de Jesus, MS, RD; Frank M. Sacks, MD, FAHA; I-Min Lee, MD, ScD; Sidney C. Smith, MD, FACC, FAHA; Alice H. Lichtenstein, DSc, FAHA; Laura P. Svetkey, MD, MHS; Catherine M. Loria, PhD, FAHA; Thomas W. Wadden, PhD; Barbara E. Millen, DrPH, RD, FADA; Susan Z. Yanovski, MD

>Download the full PDF file

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Society

Michael D. Jensen, MD; Donna H. Ryan, MD; Caroline M. Apovian, MD, FACP; Catherine M. Loria, PhD, FAHA; Jamy D. Ard, MD; Barbara E. Millen, DrPH, RD; Anthony G. Comuzzie, PhD; Cathy A. Nonas, MS, RD; Karen A. Donato, SM; F. Xavier Pi-Sunyer, MD, MPH; Frank B. Hu, MD, PhD, FAHA; June Stevens, PhD; Van S. Hubbard, MD, PhD; Victor J. Stevens, PhD; John M. Jakicic, PhD; Thomas A. Wadden, PhD; Robert F. Kushner, MD; Bruce M. Wolfe, MD; Susan Z. Yanovski, MD

Download the full PDF file

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk 

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

David C. Goff, MD, PhD, FACP, FAHA; Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA; Glen Bennett, MPH; Christopher J. O'Donnell, MD, MPH; Sean Coady, MS; Jennifer Robinson, MD, MPH, FAHA; Ralph B. D'Agostino, PhD, FAHA; J. Sanford Schwartz, MD; Raymond Gibbons, MD, FACC, FAHA; Susan T. Shero, MS, RN; Philip Greenland, MD, FACC, FAHA; Sidney C. Smith, MD, FACC, FAHA; Daniel T. Lackland, DrPH, FAHA; Paul Sorlie, PhD; Daniel Levy, MD; Neil J. Stone, MD, FACC, FAHA; Peter W.F. Wilson, MD, FAHA

Download the full PDF file